Joseph C. Galante - 24 Mar 2023 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Joseph C. Galante by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
24 Mar 2023
Net transactions value
+$1,920
Form type
4
Filing time
27 Mar 2023, 17:39:43 UTC
Previous filing
02 Mar 2023
Next filing
04 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Award $1,920 +1,000 +1.7% $1.92 58,356 24 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock award will vest 100% on March 24, 2024.